Search research articles
Contact Us
Filters
Showing results (21-30 of 235) with videos related to
Page
of 24
Sort By:
Virchows Archiv : an International Journal of Pathology
|
October 17, 2018
Recent advances in the histological and molecular classification of endometrial stromal neoplasms
Joana Ferreira, Ana Félix, Jochen K Lennerz, et al.
The Journal of Molecular Diagnostics : JMD
|
September 3, 2025
Solving the :: Fusion Nomenclature Challenge for File and Directory Naming
Tom Bisson, Stefan Kaluziak, Norman Zerbe, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2023
Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy
Ibiayi Dagogo-Jack, Lesli A Kiedrowski, Jochen K Lennerz
European Urology
|
September 20, 2016
Reply from Authors re: Emmanuel S. Antonarakis, Howard I. Scher. Do Patients With AR-V7-Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. Eur Urol 2017;71:4-6: Unsplicing a Conflict
Julie Steinestel, Christof Bernemann, Andres J Schrader, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
March 2, 2017
PAX8-positive Biphasic Synovial Sarcoma Expressing Hormonal Receptors
Leonardo Lordello, Martin E Bur, Esther Oliva, et al.
European Urology
|
September 21, 2016
Reply to Marcus V. Cronauer, Axel S. Merseburger, and M. Raschid Hoda's Letter to the Editor re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1-3
Julie Steinestel, Christof Bernemann, Andres J Schrader, et al.
European Urology
|
July 10, 2017
Re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149-56: AR-V7 Testing: What's in it for the Patient?
Julie Steinestel, Christof Bernemann, Andres J Schrader, et al.
The Oncologist
|
August 18, 2021
Two In Cis Variants-Two Worlds Apart
Ying-Chun Lo, Rupa Narayan, Valentina Nardi, et al.
NPJ Digital Medicine
|
November 15, 2022
A unifying force for the realization of medical AI
Jochen K Lennerz, Ursula Green, Drew F K Williamson, et al.
Virchows Archiv : an International Journal of Pathology
|
June 12, 2014
Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC
Konrad Steinestel, Jochen K Lennerz, Stefan Eder, et al.
Page
of 24
Search research articles
Search
Showing results (21-30 of 235) with videos related to
Sort By:
Page
of 24
Virchows Archiv : an International Journal of Pathology
|
October 17, 2018
Recent advances in the histological and molecular classification of endometrial stromal neoplasms
Joana Ferreira, Ana Félix, Jochen K Lennerz, et al.
The Journal of Molecular Diagnostics : JMD
|
September 3, 2025
Solving the :: Fusion Nomenclature Challenge for File and Directory Naming
Tom Bisson, Stefan Kaluziak, Norman Zerbe, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2023
Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy
Ibiayi Dagogo-Jack, Lesli A Kiedrowski, Jochen K Lennerz
European Urology
|
September 20, 2016
Reply from Authors re: Emmanuel S. Antonarakis, Howard I. Scher. Do Patients With AR-V7-Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. Eur Urol 2017;71:4-6: Unsplicing a Conflict
Julie Steinestel, Christof Bernemann, Andres J Schrader, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
March 2, 2017
PAX8-positive Biphasic Synovial Sarcoma Expressing Hormonal Receptors
Leonardo Lordello, Martin E Bur, Esther Oliva, et al.
European Urology
|
September 21, 2016
Reply to Marcus V. Cronauer, Axel S. Merseburger, and M. Raschid Hoda's Letter to the Editor re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1-3
Julie Steinestel, Christof Bernemann, Andres J Schrader, et al.
European Urology
|
July 10, 2017
Re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149-56: AR-V7 Testing: What's in it for the Patient?
Julie Steinestel, Christof Bernemann, Andres J Schrader, et al.
The Oncologist
|
August 18, 2021
Two In Cis Variants-Two Worlds Apart
Ying-Chun Lo, Rupa Narayan, Valentina Nardi, et al.
NPJ Digital Medicine
|
November 15, 2022
A unifying force for the realization of medical AI
Jochen K Lennerz, Ursula Green, Drew F K Williamson, et al.
Virchows Archiv : an International Journal of Pathology
|
June 12, 2014
Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC
Konrad Steinestel, Jochen K Lennerz, Stefan Eder, et al.
Page
of 24